Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Chaimani

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Systematic Reviews|September 11, 2021
Do reporting guidelines have an impact? Empirical assessment of changes in reporting before and after the PRISMA extension statement for network meta-analysisAreti Angeliki Veroniki, Sofia Tsokani, Stella Zevgiti, et al.
BMJ Open|July 13, 2016
Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysisToshi A Furukawa, Georgia Salanti, Lauren Z Atkinson, et al.
BMC Medicine|March 16, 2017
Erratum to: Characteristics and knowledge synthesis approach for 456 network meta-analyses: a scoping reviewWasifa Zarin, Areti Angeliki Veroniki, Vera Nincic, et al.
BMC Medicine|January 6, 2017
Characteristics and knowledge synthesis approach for 456 network meta-analyses: a scoping reviewWasifa Zarin, Areti Angeliki Veroniki, Vera Nincic, et al.
Annals of Internal Medicine|June 2, 2015
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanationsBrian Hutton, Georgia Salanti, Deborah M Caldwell, et al.
The Lancet. Psychiatry|April 10, 2018
Antidepressants might work for people with major depression: where do we go from here?Andrea Cipriani, Georgia Salanti, Toshi A Furukawa, et al.
The Cochrane Database of Systematic Reviews|January 26, 2022
Interleukin-1 blocking agents for treating COVID-19Mauricia Davidson, Sonia Menon, Anna Chaimani, et al.
Focus (American Psychiatric Publishing)|February 6, 2020
Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-AnalysisAndrea Cipriani, Toshi A Furukawa, Georgia Salanti, et al.
Lancet (London, England)|February 26, 2018
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysisAndrea Cipriani, Toshi A Furukawa, Georgia Salanti, et al.
Journal of Clinical Epidemiology|November 23, 2025
Including nonrandomized evidence in living systematic reviews: lessons learned from the COVID-NMA initiativeHillary Bonnet, Julian P T Higgins, Anna Chaimani, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Systematic Reviews|September 11, 2021
Do reporting guidelines have an impact? Empirical assessment of changes in reporting before and after the PRISMA extension statement for network meta-analysisAreti Angeliki Veroniki, Sofia Tsokani, Stella Zevgiti, et al.
BMJ Open|July 13, 2016
Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysisToshi A Furukawa, Georgia Salanti, Lauren Z Atkinson, et al.
BMC Medicine|March 16, 2017
Erratum to: Characteristics and knowledge synthesis approach for 456 network meta-analyses: a scoping reviewWasifa Zarin, Areti Angeliki Veroniki, Vera Nincic, et al.
BMC Medicine|January 6, 2017
Characteristics and knowledge synthesis approach for 456 network meta-analyses: a scoping reviewWasifa Zarin, Areti Angeliki Veroniki, Vera Nincic, et al.
Annals of Internal Medicine|June 2, 2015
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanationsBrian Hutton, Georgia Salanti, Deborah M Caldwell, et al.
The Lancet. Psychiatry|April 10, 2018
Antidepressants might work for people with major depression: where do we go from here?Andrea Cipriani, Georgia Salanti, Toshi A Furukawa, et al.
The Cochrane Database of Systematic Reviews|January 26, 2022
Interleukin-1 blocking agents for treating COVID-19Mauricia Davidson, Sonia Menon, Anna Chaimani, et al.
Focus (American Psychiatric Publishing)|February 6, 2020
Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-AnalysisAndrea Cipriani, Toshi A Furukawa, Georgia Salanti, et al.
Lancet (London, England)|February 26, 2018
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysisAndrea Cipriani, Toshi A Furukawa, Georgia Salanti, et al.
Journal of Clinical Epidemiology|November 23, 2025
Including nonrandomized evidence in living systematic reviews: lessons learned from the COVID-NMA initiativeHillary Bonnet, Julian P T Higgins, Anna Chaimani, et al.
Pageof 11